| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2004) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 9044SC542W |
| Parent Compound: | DULOXETINE |
Structure
| InChI Key | BFFSMCNJSOPUAY-LMOVPXPDSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C18H20ClNOS |
| Molecular Weight | 333.88 |
| AlogP | 4.63 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 21.26 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 21.0 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Urinary Incontinence | 3 | D014549 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Multiple Sclerosis | 3 | D009103 | ClinicalTrials |
| Stress Disorders, Post-Traumatic | 3 | D013313 | ClinicalTrials |
| Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Osteoarthritis | 1 | D010003 | ClinicalTrials |
Related Entries
Scaffolds
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 31526 |
| ChEMBL | CHEMBL1200328 |
| EPA CompTox | DTXSID9046443 |
| FDA SRS | 9044SC542W |
| Guide to Pharmacology | 202 |
| KEGG | D07880 |
| PubChem | 60834 |
| SureChEMBL | SCHEMBL119403 |
| ZINC | ZINC01536779 |
CONTENTS